Chester County News and Community Website
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), headquartered in West Chester, PA, is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. For more information, visit www.verrica.com.
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that it will host a virtual KOL event discussing the approval of YCANTH™ (cantharidin) topical solution for the treatment of …
Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, announced that that Ted White, Verrica President and CEO, will participate in a fireside chat at the …
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company. announced the first commercial sale of YCANTH™ to its exclusive distributor, FFF Enterprises Inc. (“FFF”).
Verrica Pharmaceuticals Announces First Sale of YCANTH to FFF Enterprises Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) issued a statement this week in support of the U.S. Food and Drug Administration’s recent action against retailers and manufacturers of …
FDA Takes Action Against Unapproved Molluscum Contagiosum Treatments: Verrica Stands in Support Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, this week announced the presentation of lesion clearance data from Part 1 of an ongoing Phase 2 …
Verrica Pharmaceuticals Announces Presentation of Lesion Clearance Data from an Ongoing Phase 2 Study of VP-315 Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, this week announced financial results for the second quarter ended June 30, 2023.
Verrica Pharmaceuticals Reports Second Quarter 2023 Financial Results Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, announced the acceptance of an abstract that will feature clinical data from the Company’s ongoing Phase 2 …
Verrica Pharmaceuticals to Present Clinical Data on VP-315 for Basal Cell Carcinoma Treatment at AAD 2023 Innovation Academy Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced the closing this week of the previously announced $125 million debt financing with OrbiMed, a leading healthcare investment firm.
Verrica Pharmaceuticals Announces Closing of $125 Million Debt Financing with OrbiMed Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced U.S. Food and Drug Administration (FDA) approval of YCANTH™ (cantharidin) topical solution for the treatment of molluscum contagiosum (molluscum) in …
Verrica Pharmaceuticals Announces FDA Approval of YCANTH™ (cantharidin) Topical Solution Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, announced that Ted White, Verrica President & Chief Executive Officer, will present at the upcoming Jefferies Healthcare …
Verrica Pharmaceuticals Announces Presentation at the Jefferies Healthcare Conference in New York Read More